-
US Army probes helicopter flyby of Kid Rock's house
-
Golden toilet statue mocks Trump near renovated White House
-
Ballroom, library, airport: Trump aims to leave his mark
-
Netanyahu vows Israel will 'crush Iran's terror regime'
-
Blasts sow panic in Burundi's main city after arsenal fire
-
Kane out of World Cup warm-up against Japan with injury
-
Iran has 'will' to end war, but seeks guarantees, president says
-
Debutant Connolly guides Punjab to narrow IPL win over Gujarat
-
Dizzying month on markets with Middle East war
-
Woods says was looking at phone before crash: accident report
-
Young antelope shot dead at Vienna zoo
-
France eyes ban on social media for under-15s
-
Syrian president meets King Charles, Starmer on London visit
-
EU says 'necessary' to reduce fuel demand to cope with energy crisis
-
Iran players in Turkey pose with photos of young war victims
-
Prince Harry lawyers call for 'substantial damages' from UK tabloids
-
Tottenham appoint De Zerbi in battle for Premier League survival
-
US Supreme Court rules against ban on 'conversion therapy' for LGBTQ minors
-
Empty streets, markets in central Nigeria's Jos after major shooting
-
Italy delays coal phase-out by over a decade
-
Stocks rise on peace hopes, oil mixed
-
Israel weathers energy shock from Iran war even as world battles crisis
-
US consumers' inflation expectations surge on Mideast war
-
Napoli threaten absent Lukaku with disciplinary action
-
German whale saga continues as struggling animal beached again
-
Chelsea's Cucurella laments 'instability' caused by Maresca exit
-
'Iran will be at World Cup' and play in US, FIFA's Infantino tells AFP
-
Stocks rise on peace hopes, oil flat
-
Senegal enacts law doubling penalty for same-sex relations
-
De Zerbi 'agrees in principle' to become new Tottenham boss - reports
-
Trump says other countries should 'just take' the Strait of Hormuz
-
Russian oil tanker docks in Cuba after US blockade relief
-
Next days in Iran war will be 'decisive': Pentagon chief
-
Indonesia rations fuel as prices soar over Mideast war
-
How Middle East war is driving up shipping costs
-
Russian tanker brings oil to Cuba as US eases blockade
-
Asia to be hit hardest by Iran war energy crisis: Kpler to AFP
-
Huawei reports slowing revenue growth in 2025
-
Sexualised deepfakes targeting actress spur German '#MeToo' moment
-
Australia head to World Cup on a high after crushing Curacao 5-1
-
Italy fertility rate fell to new low of 1.14 in 2025
-
Pakistan cricketer Zaman gets two-match PSL ban for ball tampering
-
Oil prices rise, stocks mixed on Iran war uncertainty
-
In Beirut's largest stadium, displaced people with disabilities face 'ordeal'
-
Deposed and detained: Niger president's fate unclear nearly three years on
-
Newcastle say no manager change 'at the moment'
-
Newly-hatched rare Indian bustard chick gets 50-strong guard
-
Stranded whale frees itself again off German coast
-
Archaeologists forced by Mideast war to cut short Iraq digs
-
Stranded whale frees itself again off German coast and disappears
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT